Avoid · 34/100 · high confidence

INTERPARFUMS INC (IPAR) — Council Assessment

🔴 AVOID · Score 34/100 · high confidence

A genuinely high-quality, capital-light fragrance licensor priced for perfection at its 52-week high — the quality is real, but there is no margin of safety and organic growth is stalling in an admitted 'bridge year.'

As of 2026-06-28. 18 lenses weighed in, 0 abstained. Sources: 6 filings, 15 news, 15 discussion, 1 earnings_call.

360 narrative — news & sentiment digest

Interparfums (IPAR) — Investment Briefing

Management Commentary (Q3 2025 Earnings Call)

Reported Results & Guidance

Q3 2025 net sales: $430M (+1% reported, -1% organic excluding FX)
9M 2025 net income: $140M; diluted EPS $4.36 (flat YoY)
Full-year 2025 guidance refined to ~$1.47B sales (+1% YoY) and $5.12 EPS (flat 2024)
2026 outlook: "moderate top and bottom line growth generally in line with what we are seeing this year"
2027 expected to return to "stronger growth" driven by new licenses (Off-White, L'Enchant, Gutal)

Key Segment Trends

European ops: +5% reported (Q3), +6% YTD; gross margin 66% (stable)
U.S. ops: -5% (Q3), -6% YTD (organic); gross margin declined 110 bps in Q3 due to tariffs
Strong performers: Jimmy Choo fragrances +16%, Coach fragrances +16%, Lacoste on track for $100M sales
Travel retail +15% YTD

Margin & Tariff Pressures

9M gross margin expanded 80 bps to 64.4%, but Q3 declined 40 bps to 63.5% due to ~$6M tariff impact
Without tariffs, Q3 gross margins would have improved 100 bps
Pricing actions began August; 2% average price increase implemented; company took pricing mostly on prestige/luxury brands only
Further pricing unlikely unless significant market change occurs
European-sourced products imported to U.S. subject to 10–15% tariffs; "first sale rule" workaround expected implementation by Q2 2026

Inventory & Working Capital

Inventory down 6% YoY (improved composition: higher finished goods mix)
Accounts receivable up 3% (ahead of sales growth due to channel/FX mix)
9M operating cash flow up $18M YoY to $68M (38% of net income vs. 28% prior year)
Cash position: $188M; repurchased $7.5M in shares YTD

Capital Allocation & Strategic Moves

Signed three new major licenses: Moncler (potential $100M business in 3–5 years), Off-White, L'Enchant (plus existing Gutal acquisition)
Launched Sulfurino ultra-luxury DTC boutique in Paris; targeting 100 stores by Sept 2026, 500 by end-2027
Supply chain optimization: transitioning to 100% first-party providers for packing/shipping/warehousing; nearshoring some U.S. SKUs
Women's Wear Daily named IPAR "beauty company of the year" (public company category)

Analyst Q&A: Tone & Notable Exchanges

Management confirmed strong October and November pre-orders for holiday season; no holiday demand concerns
Pricing acceptance described as "quite well accepted" by retailers and consumers; no material resistance reported
Acknowledged persistent disconnect between retail sell-in and sell-out (couple of percentage points gap); attributed to industry-wide de-stocking and AI-driven inventory optimization by retailers
Q4 gross margin expected to erode ~50 bps (similar to Q3) due to ongoing tariff lag; improvement expected Q2 2026 once first-sale rule implemented
Management tone: candid about headwinds, disciplined in execution; emphasized long-term strength over near-term noise

Recent Developments

Q4 2025 results (late Feb 2026): Q4 EPS $0.88 (+16% YoY), sales $386M (+7% YoY), organic +3%; maintained 2026 guidance at $1.48B/$4.85 EPS
Q1 2026 results (early May 2026): EPS $1.35 (+2.3% YoY), sales $345M (+1.8% YoY); maintained 2026 guidance
CEO insider selling (early April 2026): Jean Madar (CEO) sold 20,000 shares at ~$91/share (~$1.82M)
Sulfurino boutique launch (Q3 2025): First ultra-luxury DTC flagship in Paris; selective retail rollout underway

Bull Narrative

Optimist view (Seeking Alpha, Zacks analysts):

Resilient core brands: Jimmy Choo (+16%), Coach (+16%), and Lacoste tracking well; diversified portfolio mitigates risk
Long-term growth catalysts: Moncler license (potential $100M in 3–5 years) and new ultra-luxury DTC (Sulfurino) offer meaningful upside; Off-White, L'Enchant rollouts in 2027 should ignite stronger growth
Capital-light, high-margin model: 64%+ gross margins, 22%+ operating margins; minimal capex required; strong cash generation supports buybacks and dividend potential
Operational excellence: Tariff mitigation strategies (nearshoring, first-sale rule) being proactively deployed; inventory management improved; pricing power demonstrated in prestige segment
E-commerce tailwind: Fragrances 50% of beauty on Amazon; TikTok Shop and VivaBox driving smaller-size transactions; digital growing strongly
Travel retail acceleration: +15% growth; more shelf space being secured at duty-free

Bear Narrative

Skeptic view (embedded in call, analyst caution):

Growth stalling: Only +1% top-line growth in 2025; organic sales flat/declining in Q3; 2026 outlook for "moderate growth" signals continued deceleration
Tariff headwind persistence: $6M hit in Q3 alone; gross margin erosion expected to continue through Q1 2026; first-sale rule workaround won't be live until Q2 2026, leaving 6+ months of drag
Pricing elasticity risk: While 2% pricing so far hasn't caused visible pain, broader market pricing up 5–7% in Q3. IPAR's selective approach leaves room for competitors to gain share if they price less aggressively
Retail destocking reality: Sell-in lagging sell-out by 2+ percentage points; retailers using AI to right-size inventory; IPAR's inventory down 6% YoY, echoing broader industry caution
Key brand saturation: Mont Blanc "dipping," suggesting innovation fatigue; older portfolio brands being eclipsed by new acquisitions (Cavalli, Lacoste, Donna Karan additions already pressuring growth)
2026–2027 binary bet: 2026 explicitly called a "bridge year" with modest growth; meaningful upside tied to Moncler ramp and 2027 license launches—further away, higher execution risk
CEO selling: Madar trimmed $1.82M in stock (Apr 2026) near $91, suggesting interior conviction or rebalancing at lofty valuations

Retail Sentiment

Overall: Mixed to cautiously bullish, low conviction.

Bullish retail posts (Zacks, Estimize tracking, stocktwits): Praise beat rates, note record Q4 sales, highlight brand momentum (Jimmy Choo, Coach), and frame Moncler as a major catalyst. Options traders note 50–75% ROI plays on call spreads.
Neutral/cautious posts: Focus on "bridge year" characterization of 2026; acknowledge tariff drag; note insider selling; no strong conviction buy calls.
Tone: Acknowledgment that growth is "resilient" but uninspiring; fragmentation between optimism on brand strength vs. pessimism on macro/tariff headwinds.

Caveats

Earnings call transcript quality: Heavy transcription errors (e.g., "Aunter Parfum," "Enter Parfums," garbled references to adjacencies and product lines) complicate reliability of specific product commentary. Several passages are unintelligible.
Thin news flow post-Q3 2025: Most available chatter is from Feb–Jun 2026 (Q4/Q1 results, insider trades, analyst previews). Limited direct market reaction post-Q3 call itself.
FX volatility masking organic performance: Stronger euro added ~2 pts to Q3 growth and ~1 pt YTD; organic decline of -1% in Q3 highlights underlying softness. Exchange-rate dependency creates earnings opacity.
Forward guidance vagueness: "Moderate growth" and "bridge year" language is qualitative; 2026 guidance appears stable ($1.48B/$4.85 EPS) but offers no upside signaling. 2027 upside contingent on execution of three new licenses—unproven at scale.
Limited visibility into Moncler ramp: Management projects $100M in 3–5 years but provides no phase-in schedule, retail commitments, or launch timing. High execution risk.
Tariff remediation timing: First-sale rule IT build expected Q2 2026; no guarantee of on-time completion. Continued margin erosion in Q4 2025–Q1 2026 not fully priced into early guidance.
Small analyst coverage & public float: Mostly Zacks, Canaccord, Jeffries commentary; limited institutional sell-side depth. Stock liquidity appears adequate but not deep.

Bull case

IPAR is a genuinely wonderful business: capital-light licensing model, ~64% gross margins, ~22% operating margins, strong FCF conversion, a pristine balance sheet (net cash ~$160M, D/E 0.02, current ratio 3.8x), and a diversified prestige-brand portfolio (Jimmy Choo +16%, Coach +16%, Lacoste to $100M). The AI/disruption referee rightly notes it is one of the lowest AI-disruption-risk businesses possible — physical, olfactory luxury cannot be commoditized by algorithms. A robust new-license pipeline (Moncler with a $100M target, Off-White, L'Enchant) plus travel retail +15% offers a real 2027+ reinvestment runway. On corrected current numbers (~$1.48B revenue, ~$4.85 EPS), the stock trades ~22x forward earnings and ~2.3x sales — not egregious for a durable branded franchise.

Bear case

The near-unanimous value and risk bench (Klarman 18, Schloss 18, Graham 22, Marks 22, Greenwald 28, Druckenmiller 28, Greenblatt 32) plus the Damodaran-style referee (22) all flag the same thing: no margin of safety at a 52-week high. Even correcting the stale-2020 DCF, the referee's own reverse-engineering shows the price requires 10-12% sustained FCF CAGR for a decade — flatly contradicted by management's 'bridge year' framing, +1% reported / -1% organic 2025 growth, and ~5% guided 2026 EPS decline. Greenwald's normalized EPV (~$75-85) and the referee's conservative fair value (~$70-95) both sit below the $108 price. The moat is contractual, not owned (Burberry loss precedent), ROIC barely exceeds WACC, tariffs are compressing margins into Q2 2026, and the CEO sold $1.82M near $91 while the stock ran higher.

Dissent — where the council disagrees

The sharpest dissent is between the AI/Disruption referee (PASS 78 — lowest disruption risk imaginable, durable physical-luxury moat) and the entire valuation/value cohort (six AVOIDs at 18-32) plus the Damodaran referee (AVOID 22). Even the quality bulls who like the franchise — Terry Smith (58), Buffett (55), Munger/Akre/Mauboussin (52) — all land on WATCH, and every one of them names valuation as the disqualifier. Critically, NOT A SINGLE lens rates this a buy on price; the highest score comes from a referee scoring disruption risk, not investment merit. That matters to the decision: the bull case is entirely quality-and-optionality, while every price-disciplined lens says you're paying full value for flawless 2027 execution. When the referees split (AI says durable, valuation says overpriced) and the value bench is unanimous against, the price discipline should govern.

Key risks

No margin of safety: trading at 52-week high; corrected fair-value estimates ($70-95 EPV/DCF) sit below the $108 price, requiring heroic 10%+ FCF growth the company isn't guiding to
Contractual (not owned) moat — a major license non-renewal (Burberry-style) could impair franchise value rapidly
Organic growth stalled: -1% Q3 2025 organic, 2026 explicitly a 'bridge year,' 2027 upside dependent on unproven Moncler/Off-White/L'Enchant ramps
Tariff margin drag (~$6M/quarter) persisting until first-sale-rule fix in Q2 2026, with only 2% pricing taken vs 5-7% industry — weak inflation pass-through
CEO sold $1.82M near $91 while stock ran to $108 — insider conviction lags street enthusiasm
Sulfurino DTC build (500 stores by 2027) risks eroding the capital-light thesis and stretching a B2B-native management team

Catalysts

Q2 2026 gross margin recovery once first-sale-rule tariff workaround goes live
Moncler / Off-White / L'Enchant license ramps driving the promised 2027 growth reacceleration
Guidance cut risk if the sell-in vs sell-out gap and retailer destocking worsen
Further insider Form 4 selling by CEO Madar
Sulfurino DTC unit economics disclosure (capex/lease commitments)

DCF valuation (finance-expert model)

two-stage DCF, Gordon terminal value, CAPM-weighted WACC.

Intrinsic value: $28.04/share vs price $107.97 → -74% (bear $25.28 · base $28.04 · bull $34.09).

Step	Value
Base free cash flow	$54M
FCF growth (yrs 1-5)	2.0% (revenue CAGR)
WACC (β 1.107)	9.8%
Terminal growth	2.5%
PV of explicit FCF	$217M
PV of terminal (residual) value	$522M (71% of EV)
Enterprise value	$740M
less Net debt	$-160M
= Equity value	$899M
/ Shares (32M) = intrinsic/share	$28.04

Short-sell evaluation

🚫 AVOID SHORTING

Despite obvious overvaluation and decelerating growth, this is a poor short. The forensic short-seller landed on WATCH (52), not short, precisely because the accounting is clean, FCF is positive and tracks net income, gross margins are genuinely ~64%, and the balance sheet is a fortress (net cash ~$160M, D/E 0.02, current ratio 3.8x) — ruling out the classic Chanos bankruptcy/leverage thesis. The overvaluation is against fair value (~$75-95), not against a collapsing business, so the downside is a re-rating of a healthy, cash-generative compounder — modest and slow, not a fraud unwind. With durable brand cash flows, buybacks, a founder-led base, and low-disruption-risk physical luxury demand, the borrow cost and squeeze/asymmetry risk of shorting a quality name near fair-to-rich value outweigh the reward. A short only works if Moncler/2027 licenses fail AND tariffs persist AND a guidance cut lands — a multi-condition bet unsuitable outside a specialist book.

Pros (the short could work)

Trading at 52-week high with no margin of safety; corrected fair value (~$75-95) sits ~15-30% below price, giving genuine downside on any multiple compression
Growth decelerating into a self-described 'bridge year' — guidance cut is the most plausible near-term catalyst, especially given sell-in lagging sell-out by 2+ points
Tariff margin erosion unresolved until Q2 2026; weak 2% pricing power against 5-7% industry norms
ROIC barely above WACC — growth is only marginally value-creating, undermining the compounder premium
Insider selling by the CEO near recent highs signals lower internal conviction than the street

Cons (what kills the short)

Fortress balance sheet (net cash ~$160M, minimal debt, 3.8x current ratio) and strongly positive FCF — no financial distress vector for the short
Clean accounting: FCF tracks net income, the core Chanos test does not fire
Durable, low-disruption physical-luxury franchise (AI referee PASS 78) with genuine ~64% margins and brand pricing power — quality kills shorts
Founder-led, buybacks and dividends, and cautiously bullish sentiment provide price support; no capitulation dynamic to exploit
Asymmetry of unlimited downside on shorting a fairly-valued quality name whose 2027 license optionality could re-rate it higher
This is a modest overvaluation of a good business, not a broken thesis — the wrong profile for an attractive short

Council scorecard

Lens	School	Stance	Score	Conf
AI & Disruption Referee (Christensen-style)	referee	🟢 pass	78	medium
Terry Smith (Fundsmith)	quality	🟡 watch	58	medium
Warren Buffett	quality	🟡 watch	55	medium
Chuck Akre	quality	🟡 watch	52	medium
Philip Fisher	growth	🟡 watch	52	medium
Charlie Munger	quality	🟡 watch	52	medium
Forensic Short-Seller (Chanos/Einhorn-style)	referee	🟡 watch	52	medium
Michael Mauboussin	quality	🟡 watch	52	medium
Ray Dalio	risk	🟡 watch	48	medium
Joel Greenblatt	value	🔴 avoid	32	high
Stanley Druckenmiller	risk	🔴 avoid	28	high
Bruce Greenwald	value	🔴 avoid	28	medium
Peter Lynch	growth	🔴 avoid	28	high
Valuation Referee (Damodaran-style)	referee	🔴 avoid	22	high
Benjamin Graham	value	🔴 avoid	22	high
Howard Marks	risk	🔴 avoid	22	high
Seth Klarman	value	🔴 avoid	18	high
Walter Schloss	value	🔴 avoid	18	high

Member reasoning

AI & Disruption Referee (Christensen-style) — 🟢 pass · 78/100 · medium confidence

Interparfums is a licensed fragrance house whose core product is physical luxury goods — bottled scent, packaging, and brand prestige. The 'job' IPAR does for customers is provide an olfactory aesthetic experience anchored in designer brand identity (Jimmy Choo, Coach, Moncler, Lacoste, etc.). This is about as far from knowledge-work or digital intermediation as a consumer business gets. AI cannot synthesize a bottle of Jimmy Choo perfume, cannot replicate the tactile/olfactory luxury ritual, and cannot disintermediate the physical supply chain that IPAR operates. The disintermediation test largely fails to apply: there is no toll-taking routing function; the value is in IP licensing relationships, formulation craft, and physical distribution into prestige retail and duty-free. That said, AI does introduce second-order risks and some genuine tailwinds worth scoring carefully. On the threat side: (1) AI-assisted fragrance formulation could lower barriers for new entrants and reduce the craft moat in scent creation — startups like Osmo and Givaudan's AI tools are already compressing formulation timelines; (2) AI-driven retail inventory optimization (explicitly mentioned in the Q3 earnings call as causing sell-in vs. sell-out gaps) is structurally compressing wholesale order patterns, a real near-term headwind; (3) AI-generated marketing creative and social commerce (TikTok) democratizes brand discovery, potentially diluting incumbent licensed-brand premium over time. On the tailwind side: (1) IPAR itself benefits from AI-assisted product development (faster line extensions, lower R&D cost); (2) AI personalization in e-commerce (Amazon, Sephora) could surface IPAR's diverse portfolio more efficiently; (3) management explicitly noted fragrances are 50% of beauty on Amazon — a platform IPAR is positioned to benefit from algorithmically. The Sulfurino DTC boutique initiative also shows some awareness of owning the customer relationship, though 100→500 stores is an ambitious physical build-out. The management AI mention is limited to acknowledging retailer inventory AI as a headwind — no explicit own-displacement risk acknowledged and no AI product strategy articulated, which is honest but not forward-thinking. The Moncler and Off-White licenses create long-duration brand dependency that is structurally resistant to AI commoditization (you cannot AI-generate a Moncler brand partnership). Critically, the biggest Christensen-style risk — a cheaper, initially-inferior alternative displacing the incumbent — maps poorly here. Celebrity/indie fragrance brands (e.g., direct-to-consumer via TikTok) could be viewed as a low-end disruption, but IPAR's licensed prestige positioning sits in the mid-to-high tier, not the vulnerable mass-market bottom. The falsifiable bearish call on AI would be: AI formulation tools + celebrity DTC + platform commoditization cause prestige fragrance volume to shift toward unbranded/private-label at scale, and IPAR's license renewal rates or royalty terms deteriorate. The falsifiable bullish call: IPAR integrates AI into faster product launches, personalization improves sell-through, and licensed brand moat compounds because AI if anything strengthens consumer preference for authenticated luxury identity. On balance, IPAR is one of the lower AI-disruption-risk businesses a council could evaluate — physical luxury goods with strong licensed brand identity and a capital-light model that benefits modestly from AI cost tailwinds without facing a credible AI-native substitute.

Key points

Core product is physical/olfactory luxury — no AI can replicate the bottled scent experience or substitute the brand prestige ritual; disintermediation test fails to apply
Licensed brand relationships (Moncler, Jimmy Choo, Coach, Lacoste) are legally exclusive, long-duration, and not replicable by AI-native competitors — the moat is contractual and brand-equity-based, not data/algorithm-based
AI-driven retail inventory optimization is a documented near-term headwind (sell-in vs. sell-out gap cited on Q3 call), but this is a structural wholesale channel pressure, not an existential obsolescence risk
AI formulation tools (Givaudan, Osmo, startups) lower entry barriers for new fragrance brands over a 5-10 year horizon, modestly eroding the formulation craft moat
E-commerce and TikTok Shop tailwinds are real and favor IPAR's diverse portfolio — algorithmic discovery benefits breadth of SKUs; management noted fragrances are 50% of beauty on Amazon
Sulfurino DTC boutique (ultra-luxury, 500-store target by end-2027) is a nascent but directionally correct move toward owning the consumer relationship — reduces intermediary dependency
Celebrity/indie DTC fragrance (a low-end disruption analog) targets mass/Gen Z segment, not IPAR's prestige/travel-retail core; limited overlap reduces Christensen-style substitution risk

Red flags

AI formulation commoditization risk is real over 10 years: if Givaudan/Firmenich AI tools allow any brand to cheaply develop competitive fragrances, IPAR's formulation expertise becomes less differentiated at contract renewal time
Management AI commentary is limited to acknowledging retailer inventory AI as a demand headwind — no proactive AI strategy articulated for their own supply chain, formulation, or consumer personalization; not in denial but not forward-leaning
Retailer AI inventory optimization (explicitly named on earnings call) is structurally compressing order visibility and creating sell-in volatility — not temporary noise, likely a permanent structural shift in how wholesale reorders are managed
CEO insider selling ($1.82M at ~$91) and description of 2026 as a 'bridge year' suggest management itself is uncertain about near-term growth, even if not AI-specifically driven
DTC Sulfurino initiative (100→500 stores by 2027) is highly ambitious for a company whose core competency is B2B licensing, not retail operations — execution risk could absorb management bandwidth if macro weakens

Terry Smith (Fundsmith) — 🟡 watch · 58/100 · medium confidence

Interparfums passes the quality screen on several dimensions — high gross margins (~64%), genuine brand licensing moat, capital-light model, and strong FCF conversion — but fails on valuation (the most critical Fundsmith second-leg criterion) and raises concerns on returns sustainability and growth deceleration. The fundamentals data in the fact base is anchored to fiscal year 2020 (a COVID-depressed year), which severely distorts headline metrics like ROE (7.1%) and ROIC (10.1%), but more recent data from earnings calls and news confirms the business has recovered strongly: Q4 2025 sales $386M (+7%), Q1 2026 sales $345M; full-year 2025 guidance ~$1.47B, 2026 guide $1.48B/$4.85 EPS. Operating margins in the European segment (~66% gross) are genuinely high. The licensing model is asset-light by design — IPAR does not own the brands, it licenses them, which keeps capex minimal ($11M on ~$71M 2020 revenue base, and capex ratio would be far lower on $1.4B+ current revenue). FCF conversion has been strong historically (FCF margin 63-76% of revenue across 2018-2020 period, though these are small-base years). The balance sheet is pristine: long-term debt just $10M, $169M cash (2020), net cash position confirmed at ~$159M net debt negative per the DCF. However, the DCF intrinsic value ($28/share base case) vs. current price ($108) implies a massive 74% overvaluation — the model uses 2020 depressed FCF ($54M) and only 2% growth, which dramatically understates current earnings power, but even generously adjusting for current-run-rate FCF closer to $200-250M (implied by $1.48B revenue at historical margins), the stock at $108 on ~32M shares ($3.46B market cap) trades at roughly 14-17x FCF. That is a fair-to-rich price for a business growing organically at only 1-3% in 2025-2026. Fundsmith demands predictable, recurring, resilient demand — fragrance licenses are repeat-purchase but portfolio concentration in licensed brands creates key-person/key-contract risk (loss of a major license like Jimmy Choo, Coach, or Montblanc would be material). Tariff headwinds ($6M Q3 impact alone), 2026 as an explicitly called 'bridge year,' and CEO selling at ~$91 are incremental negatives. The Moncler and new license pipeline is promising but unproven. Growth deceleration to 1% organic in 2025 (with Q3 organically negative) is below the threshold where the compounding magic works efficiently. ROCE using current earnings would be meaningfully better than the 10% shown in 2020, but still likely below the 20%+ sustained standard Smith prefers — the business has intangible-heavy assets (license agreements, brand goodwill) that flatter capital-light optics but carry renewal risk.

Key points

Capital-light licensing model with ~64% gross margins and minimal capex is structurally attractive to Fundsmith framework
Balance sheet is excellent: net cash of ~$159M, negligible long-term debt ($10M), current ratio 3.85x — no leverage risk
Strong FCF conversion historically (63-76% FCF margin on revenue in 2018-2020), with operating cash flow improving YTD 2025
Diversified, recognizable brand portfolio (Jimmy Choo +16%, Coach +16%, Lacoste ~$100M) provides genuine repeat-purchase demand
New license pipeline (Moncler, Off-White, L'Enchant) offers multi-year reinvestment runway with high incremental returns if executed
Pricing power demonstrated: 2% average price increase implemented in August 2025 with minimal retailer resistance in prestige segment

Red flags

Valuation is the primary disqualifier: at $108/share ($3.46B market cap) vs. even optimistic FCF of $200-250M, the yield is 6-7% — acceptable but not compelling for a 1-3% organic grower facing near-term headwinds
Organic growth decelerating sharply: Q3 2025 organic sales -1%, full-year 2025 essentially flat organically; 2026 described as a 'bridge year' — antithetical to the compounding thesis
License dependency is a structural risk Smith would scrutinize: IPAR does not own its brands; contract renewal or loss of a top-5 brand (Montblanc, Jimmy Choo, Coach) would be highly disruptive
CEO Jean Madar sold 20,000 shares at ~$91 in April 2026 — while not alarming alone, it is a negative signal from the principal
Tariff headwinds ($6M+ quarterly impact) compressing gross margins; mitigation (first-sale rule workaround) not live until Q2 2026 — 6+ months of margin drag
Fundamentals data anchored to 2020 (COVID trough) creates significant noise in stated ROE (7.1%) and ROIC (10.1%) — current returns are better but still uncertain without recent 10-K detail

Warren Buffett — 🟡 watch · 55/100 · medium confidence

Interparfums is a genuinely interesting business with several Buffett-compatible qualities: a capital-light licensing model in the prestige fragrance space, strong gross margins (64%+), minimal debt (debt-to-equity 0.019), a solid current ratio (3.85), and recognizable brand names (Jimmy Choo, Coach, Lacoste, Montblanc). The business is understandable — they license fashion brands, manufacture/distribute fragrances, and collect royalties on brand equity they do not own. The economics are asset-light and the cash conversion is good (FCF margin ~62-76% historically). However, several concerns prevent a 'pass' verdict. First and most importantly, the valuation is deeply problematic: the DCF intrinsic value is ~$28/share versus a current price of ~$108 — implying roughly 74% overvaluation even under generous assumptions. The DCF uses only 2% growth anchored on a COVID-depressed 2020 revenue base ($71.5M reported vs. more recent $1.4B+ run-rate), making the model mechanically flawed, but even adjusting upward significantly, the P/E of 90x (on 2020 earnings) and price-to-sales of 48x are extreme. On more current financials (2025 full-year ~$1.47B sales, ~$4.85 EPS guidance), the stock at $108 trades at roughly 22x earnings — more reasonable but still not cheap for a business growing organically at 1-3%. Second, ROE of 7.1% (on 2020 base) understates normalized returns, but even on current earnings the returns are modest for the premium being paid. Third, the moat is real but structurally limited: Interparfums does not own the brand equity — they license it. If a license expires or is not renewed (Burberry was famously lost in 2017), significant revenue can evaporate. This is a key vulnerability versus a true Buffett-quality moat where the company owns the brand outright (think See's Candies, Coca-Cola). Fourth, the CEO sold $1.82M in stock at ~$91/share in April 2026, which is a yellow flag on management conviction. Fifth, 2026 is explicitly a 'bridge year' with modest growth, and meaningful upside is contingent on unproven new license ramps (Moncler, Off-White) — more story-dependent than proven earnings power. The business has genuine quality characteristics and earns consideration, but the combination of license-dependency rather than owned moat, modest near-term growth, and a valuation offering no margin of safety keeps this in the watch category.

Key points

Capital-light licensing model with 64%+ gross margins and strong FCF conversion — genuinely asset-light economics I appreciate
Virtually debt-free balance sheet (D/E 0.019) with $169M+ cash; can self-fund through downturns
Diversified portfolio of prestige licenses reduces single-brand concentration risk; Jimmy Choo +16%, Coach +16% in recent quarters
Recent 2025/2026 revenue run-rate ~$1.47B vs. the DCF's $71.5M base year (2020 COVID trough) — the DCF dramatically understates the business; current P/E on 2026 guidance (~$4.85 EPS) is ~22x, not 90x
Business model is understandable and has operated profitably through multiple cycles including COVID

Red flags

Licenses rather than owned brand equity — fundamental moat limitation; license loss (like Burberry in 2017) can be severe and permanent
Current price (~$108) vs. DCF intrinsic ($28 base, $34 bull) shows extreme overvaluation even accounting for the model's depressed FCF base — no margin of safety at any reasonable assumption set
CEO Jean Madar sold $1.82M in stock at ~$91/share in April 2026, reducing insider conviction signal
2026 explicitly a 'bridge year' with only 1-3% organic growth; meaningful upside is execution-dependent on new, unproven license ramps (Moncler 3-5 year horizon)
Tariff headwinds eroding U.S. gross margins (~$6M hit in Q3 2025 alone); first-sale rule workaround not live until Q2 2026 at earliest
Montblanc described as 'dipping' — some portfolio fatigue in older licenses; innovation dependency creates earnings lumpiness

Chuck Akre — 🟡 watch · 52/100 · medium confidence

Interparfums has several characteristics I find attractive — a capital-light licensing model with impressive gross margins (64%+), meaningful free cash flow conversion, and a diversified portfolio of prestige fragrance brands. However, applying the three-legged stool rigorously, the company falls short on enough dimensions to prevent a confident 'pass.' The business quality is genuine but the returns on equity and reinvestment economics are weaker than my typical targets. The fundamentals data (2020 base period) shows ROE of only 7.1% and ROIC of ~10%, well below the 20%+ threshold I prize. Even accounting for COVID distortion in 2020, the structural ROE hasn't demonstrated sustained 20%+ returns with the kind of compounding consistency I require. The reinvestment runway is real but execution-dependent — Moncler license is promising but 3-5 years out with no phase-in schedule; Sulfurino ultra-luxury DTC is a small, unproven concept; and 2026 is explicitly a 'bridge year.' Management under Jean Madar has built a credible licensing business, but the CEO sold $1.82M in stock near current levels in April 2026, which creates mild integrity/conviction concern rather than disqualifying red flag. Capital allocation has been reasonable (buybacks, dividends) but not exceptional. The valuation is the clearest disqualifier from an Akre perspective: the DCF intrinsic value estimate is $28/share against a current price of $108 — an 74% premium to intrinsic value by the model's own math (even granting the model uses COVID-depressed 2020 FCF as base, actual 2025-level revenue implies ~$1.47B sales vs $71.5M in the base period, so the DCF is severely understated). Using more current numbers — 2025 full-year implied FCF at ~$180-200M range given management's $4.85 EPS guidance and ~32M shares — the business trades at roughly 17-19x FCF. At that level, for a business growing organically at 1-3% currently, you are paying a full-to-premium price. Akre would pay up for a compounder, but the compounding rate must justify the multiple. With organic growth stalling at 1%, tariff headwinds eating margins, no reinvestment proof yet on major new licenses, and a 'bridge year' narrative for 2026, I cannot justify paying a premium multiple today. The stock is not egregiously overvalued for a quality franchise, but it offers no margin of safety and limited near-term compounding upside. I watch but do not own at this price.

Key points

Capital-light licensing model with 64%+ gross margins is genuinely attractive — fits the franchise business archetype
Diversified brand portfolio (Jimmy Choo, Coach +16%, Lacoste tracking to $100M) provides revenue resilience across cycles
Free cash flow conversion is strong — FCF margins historically 62-76%; operating cash flow growing
New license pipeline (Moncler, Off-White, L'Enchant) provides a real reinvestment runway, though execution is 2027+ dependent
Management has built a credible, long-tenured business with rational licensing strategy and measured capital allocation
Balance sheet is clean: debt-to-equity only 0.019, net cash of ~$160M, no leverage-driven ROE concerns
Pricing power demonstrated in prestige segment — 2% price increase absorbed with minimal retailer resistance

Red flags

ROE of only 7.1% and ROIC of ~10% (2020 base) — far below the 20%+ sustained returns I require; even cyclically-adjusted, structural returns appear mediocre by compounding-machine standards
Reinvestment runway is real but unproven at scale — Moncler $100M target is 3-5 years away, Sulfurino DTC is nascent; 2026 explicitly a 'bridge year' with only 1-3% organic growth
CEO Jean Madar sold $1.82M in stock (~20,000 shares) at ~$91 in April 2026 — raises mild conviction concern at a moment when stock should theoretically be cheap if management believed in the compounding story
Organic growth stalling: Q3 2025 organic sales -1% (reported +1% only via FX); 9-month EPS flat YoY; growth deceleration is real, not just cyclical
Tariff headwinds ($6M Q3 hit, margin erosion continuing through Q1 2026) with first-sale rule fix not live until Q2 2026 — near-term earnings quality impaired
Current price of $108 at 52-week high implies no margin of safety; even using current-year FCF estimates the stock trades at 17-19x FCF for a 1-3% organic grower — full price for the quality level offered
DCF model (understated due to 2020 base) still illustrates the valuation problem — market is pricing in many years of flawless execution on new licenses not yet proven

Philip Fisher — 🟡 watch · 52/100 · medium confidence

Interparfums presents a classic licensing-model fragrance business with genuine brand quality and capital-light economics, but it fails several of my core criteria. On the growth front, the data is concerning: the fundamentals block shows a 2-year revenue CAGR of -13.3% (using 2018-2020 data, which includes COVID distortion), and more importantly, 2025 organic growth was approximately flat to -1% in Q3, with full-year 2025 at only +1% reported. Management explicitly labeled 2026 a 'bridge year' with 'moderate growth.' This is not the sustained above-industry organic growth runway I require. Q1 2026 revenue of $345M was up only 1.8% YoY. The bull case rests almost entirely on future license ramp-ups (Moncler, Off-White, L'Enchant) targeting 2027+, which is speculative rather than demonstrated. On the positive side: gross margins of 64%+ and operating margins above 22% are genuinely superior for consumer goods; the capital-light model (low capex, high FCF conversion) is excellent; management's candor about tariff headwinds, the 'bridge year' framing, and direct disclosure of the first-sale rule workaround timing reflect the transparency I respect. The Moncler license and Sulfurino DTC initiative show long-term orientation. However, IPAR's model is fundamentally about acquiring licensed brands rather than proprietary R&D-driven product innovation — there is no meaningful R&D spend in the traditional sense, which is a structural gap against my criteria. Growth is purchased through license agreements and brand partnerships, not earned through internal innovation pipelines. The CEO insider sale of $1.82M at ~$91 in April 2026 while the stock has run to $108 adds a note of caution. The DCF intrinsic value of $28/share vs. $108 current price signals massive valuation risk, though the DCF uses stale 2020 base FCF — actual 2025-2026 FCF on $1.47B+ revenue would be far higher — but even generously adjusting, the premium embedded is very high for a company guiding to flat-moderate growth through 2026.

Key points

Capital-light licensing model generates 64%+ gross margins and strong FCF — genuinely superior unit economics that I find attractive
Management candor is commendable: explicitly called 2026 a 'bridge year,' disclosed tariff impacts of ~$6M in Q3 2025, gave transparent timing on first-sale rule implementation — this is the honesty I require
New license pipeline (Moncler $100M potential in 3-5 years, Off-White, L'Enchant) demonstrates long-term thinking over short-term optimization
Jimmy Choo +16% and Coach +16% in fragrance lines show the sales/marketing organization is capable of turning licensed brands into real share gains
Travel retail +15% YTD and digital/e-commerce growth (50% of beauty on Amazon) represent genuine market expansion vectors
Debt-to-equity of only 0.019 and $188M cash give the balance sheet strength to execute multi-year license ramp without dilution

Red flags

Organic growth is stalling: Q3 2025 organic sales -1%, full-year 2025 guidance +1% reported — this is not the above-industry growth trajectory I require; 'bridge year' language for 2026 compounds the concern
No true R&D engine: IPAR's growth model is license acquisition, not proprietary innovation — there is no R&D pipeline converting into new science-driven products, which structurally limits my enthusiasm
DCF model (even with stale 2020 base FCF) points to massive overvaluation; the market is pricing in a very optimistic scenario with little margin of safety for a growth-stalling period
CEO Jean Madar sold $1.82M in shares at ~$91 in April 2026 — insider selling near 52-week highs during a self-described 'bridge year' is a red flag on internal conviction
Mont Blanc 'dipping' signals portfolio maturation/innovation fatigue in flagship brands; growth is increasingly dependent on newer, unproven licenses rather than the core franchise
Tariff headwinds ($6M Q3 2025 hit, margin erosion continuing through Q1 2026) represent a structural drag on margins that is not fully resolved; first-sale rule workaround relies on IT implementation timeline with execution risk
2026-2027 upside is binary and back-loaded: meaningful acceleration requires successful Moncler ramp and three new license launches — all speculative at this stage with no retail commitments disclosed

Charlie Munger — 🟡 watch · 52/100 · medium confidence

Interparfums is a genuinely interesting business — a capital-light, brand-licensing fragrance platform with high gross margins (64%+), meaningful free cash flow, and an understandable model I could explain in a paragraph: they license prestige fashion brands, manufacture fragrances largely through French operations, and distribute globally. The moat elements are real — license exclusivity, brand association with houses like Jimmy Choo, Coach, Lacoste, and Moncler creates pricing power that shows up in gross margins stable around 64% over cycles. Debt is essentially nil (D/E ~0.02), current ratio nearly 4x, and cash on balance sheet of ~$188M provides resilience. So the business quality is genuine.

However, several concerns prevent a full endorsement. First and most critically, the price is simply too high. The DCF at base case yields ~$28/share intrinsic value against a $108 current price — a 74% premium. Even granting that the DCF uses stale 2020 revenue as its base (IPAR now runs ~$1.47B in annual sales, a dramatically different scale), the current P/E of ~22x on forward EPS of ~$4.85 (2026 guidance) and price-to-FCF near 64x on reported figures leave little margin of safety for a business showing only 1-2% top-line growth. The quality is there; the price absorbs nearly all the good news and then some.

Second, the moat has a structural fragility: IPAR does not own the brands. The moat lives in licenses that can be terminated, renegotiated, or expire. This is meaningfully different from owning the brand outright. When Mont Blanc dips and older licenses show innovation fatigue, the reinvestment runway narrows and brand succession (Off-White, Moncler) carries execution risk.

Third, growth is genuinely stalling. 2025 organic growth was essentially flat; 2026 is explicitly called a 'bridge year.' For a compounder thesis to work, I need reinvestment at high incremental returns — and right now the reinvestment story is uncertain, dependent on Moncler ramp (3-5 years, no phase-in schedule) and the unproven Sulfurino DTC expansion.

Fourth, CEO selling 20,000 shares at ~$91 in April 2026 is a mild negative signal, though not alarming at a founder-led company.

The business earns a watch — it's quality, it's understandable, the balance sheet is clean. But I won't pay nearly 4x intrinsic value for a brand-licensing business in a growth lull with license-dependency risk. Munger's rule: it's better to buy a wonderful company at a fair price than a fair company at a wonderful price — but at these prices, even a wonderful company is a poor investment.

Key points

Capital-light fragrance licensing model with 64%+ gross margins is understandable and genuinely moaty within its license structure
Near-zero debt (D/E 0.02), $188M cash, current ratio ~4x — balance sheet survives downturns comfortably
Strong free cash flow generation historically ($54-71M range in recent history; now dramatically higher given $1.47B revenue scale vs stale 2020 base in fact base)
Diversified brand portfolio (Jimmy Choo, Coach, Lacoste, Moncler incoming) reduces single-brand concentration risk
Management appears candid in earnings calls about tariff headwinds and bridge-year characterization — not promotional

Red flags

Price at $108 implies ~74% premium to DCF intrinsic value; P/FCF ~64x on reported figures leaves no margin of safety
IPAR licenses brands rather than owning them — the moat is real but structurally more fragile than an owned-brand compounder
Organic growth flat to negative in 2025; 2026 explicitly a 'bridge year'; compounder thesis requires high-return reinvestment which is currently unclear
Moncler upside ($100M in 3-5 years) and Sulfurino DTC are unproven at scale — forward growth depends on execution of unverified strategies
CEO Jean Madar sold $1.82M in stock near $91 in April 2026 — modest but directionally negative insider signal
DCF fact base uses stale 2020 revenue figures; even adjusting materially upward for current scale, stock remains expensive on any reasonable terminal growth assumption

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 52/100 · medium confidence

IPAR presents a mixed forensic picture. The fundamental accounting quality is actually decent — operating cash flow and FCF are positive and broadly track net income — but the DCF fact base is using stale 2020 data (revenue $71.5M, net income $38M) that dramatically understates the current business (2025 revenue ~$1.47B, 2026 guided $1.48B), making the intrinsic value output ($28/share) meaningless as a forensic reference. The real current-period data from news/earnings calls shows a profitable, cash-generative business. However, several forensic yellow flags warrant a 'watch' rather than 'pass': (1) CEO Jean Madar sold $1.82M of stock at ~$91 in April 2026, which is insider selling near the high end of recent range — not conclusive but a flag; (2) The narrative explicitly describes a 'bridge year' in 2026 with growth stalling (+1% organic Q3 2025, -1% organic excluding FX), yet management maintains $1.48B/$4.85 EPS guidance — the risk of a guidance cut is real; (3) The P/E of 90x and price-to-sales of 48x (per the 2020-era fundamentals shown, though likely distorted) appear extreme; using current-period data of ~$4.85 EPS guidance vs $108 price implies ~22x forward P/E, which is elevated but not absurd for a branded consumer name; (4) Tariff headwinds causing ~$6M quarterly margin drag with first-sale rule remediation not live until Q2 2026 creates near-term earnings quality risk; (5) Receivables growing faster than revenue (A/R up 3% vs sales up ~1.8% in Q1 2026) is a minor DSO creep signal worth monitoring; (6) The Sulfurino ultra-luxury DTC buildout (100 stores by Sept 2026, 500 by end-2027) represents a capitalization-of-costs risk and a shift from the asset-light model that has historically driven cash conversion. The model is NOT a classic short — FCF is positive, gross margins at 64%+ are real, debt is negligible ($10M LTD vs $169M+ cash), and the current ratio of 3.8x is fortress-like. The kill question: this becomes a genuine short if (a) the Moncler/Off-White/L'Enchant licenses fail to ramp as projected and 2027 growth disappoints, (b) Sulfurino capex escalates and destroys the capital-light thesis, (c) tariff remediation is delayed causing sustained margin compression, or (d) A/R DSO continues to creep suggesting channel stuffing. The bear case is falsifiable: watch Q2 2026 gross margin (should improve once first-sale rule kicks in), watch A/R relative to sales each quarter, and watch insider Form 4s for further Madar selling. Currently the stock is 23% below its 52-week high of $139.94 but at its reported last close of $107.97 — though price data shows conflicting signals (52w high=107.97 elsewhere). The forensic verdict is 'watch not short': the accounting is reasonably clean but valuation, growth deceleration, CEO selling, and DTC capital commitment deserve ongoing scrutiny.

Key points

FCF positive and broadly tracks net income — no persistent earnings-vs-cash divergence in the most recent reported periods; the core Chanos test does not fire cleanly
Current financials (2025 revenue ~$1.47B, guided EPS $4.85) vs the fact base's stale 2020 data ($71.5M revenue) renders the DCF ($28 intrinsic) useless — the forensic analyst must note this data quality issue explicitly
Gross margins 64%+ and operating margins 22%+ appear genuine and supported by cash conversion; capital-light licensing model historically validates earnings quality
Balance sheet is genuinely strong: ~$188M cash, only $10M LTD, current ratio 3.8x — no debt wall, no refinancing risk, no covenant stress; this rules out the classic Chanos bankruptcy-in-waiting thesis
Accounts receivable growing 3% vs revenue +1.8% in Q1 2026 — minor DSO creep, not alarming but directionally worth tracking across 2-3 more quarters
Sulfurino DTC build (500 stores by end-2027) represents a material shift from asset-light model; capex and lease obligations from this initiative could inflate capitalized costs and suppress future FCF relative to reported earnings
2026 described as 'bridge year' with organic growth flat/negative; management maintaining $1.48B/$4.85 EPS guidance despite headwinds — guidance cut risk is the most plausible near-term catalyst for a bear thesis

Red flags

CEO Jean Madar sold 20,000 shares at ~$91 (April 2026, ~$1.82M proceeds) — insider selling near a period of acknowledged growth deceleration and tariff headwinds; not clustered or extreme but directionally negative
Tariff-related gross margin erosion ($6M Q3 2025 hit) with remediation (first-sale rule IT build) not expected live until Q2 2026 — creates 6+ months of unmitigated drag that may not be fully reflected in guidance
Organic revenue decline of -1% in Q3 2025 (excluding FX tailwind) while management characterizes performance as 'on track' — potential for narrative-vs-reality gap if FX reverses
Sulfurino 500-store DTC rollout by end-2027 introduces operating lease and capex obligations inconsistent with the capital-light model that justifies premium multiple; no financial detail on unit economics provided in filings
Mont Blanc described as 'dipping' — innovation fatigue in a key brand without clear replacement catalyst in near term
Sell-in lagging sell-out by 2+ percentage points (management's own admission); retailer AI-driven destocking could accelerate, compressing near-term revenues beyond guidance
Stale fundamentals data in fact base (2020 period) creates opacity; analyst must rely on news/call summaries rather than verified SEC filing line items for current-period forensic testing — data gap limits confidence

Michael Mauboussin — 🟡 watch · 52/100 · medium confidence

Interparfums operates as a licensing-based fragrance business with demonstrably high gross margins (~64%), but the ROIC/WACC spread analysis reveals a nuanced picture. The 2020 financials in the fact base show ROIC of ~10.1% against a WACC of ~9.8% — essentially zero spread, which is the core problem. However, more recent data (2025 full-year: ~$1.47B revenue, $4.85+ EPS vs. 2020's $71.5M revenue snapshot) suggests the business has scaled dramatically post-COVID, implying meaningfully higher absolute returns. The fundamentals block appears to reflect 2020 data (revenue $71.5M, FCF $54M) while the narrative references 2025 revenue of ~$1.47B and Q1 2026 sales of $345M — a critical data inconsistency that undermines confidence in the stated ROIC/WACC. Working backward from price: at $108/share × 32M shares = ~$3.46B market cap, with $1.47B in 2025 revenue, the price-to-sales is ~2.35x (not the 48x the fact base incorrectly computes using 2020 revenue) and assuming ~20% operating margins implies ~$294M operating income. That implies a P/EBIT near 12x — not obviously extreme. The DCF intrinsic value of $28/share uses 2020 FCF as base, making it essentially useless — the model anchors on a COVID-trough year and applies 2% growth, severely undervaluing a business that grew from $71M FCF to likely $250M+ FCF by 2025. The moat analysis: IPAR's model is licensing-based — it licenses prestigious brand names (Jimmy Choo, Coach, Moncler, Lacoste, Kate Spade) and applies operational excellence in fragrance development and distribution. This is a genuinely differentiated model but the moat sources are somewhat conditional. The intangible (brand) advantage is real but inherited rather than owned — IPAR does not own the brands, it licenses them, meaning the moat is dependent on licensor relationships and renewal economics. Switching costs are moderate at best: retailers can substitute one prestige fragrance brand for another. Scale economies are real in European manufacturing and distribution. Network effects are absent. The licensing moat is narrow-to-moderate: it strengthens when IPAR builds track record with licensors (demonstrated with Coach, Lacoste scaling toward $100M), but is structurally capped by licensor bargaining power at renewal. The 64%+ gross margin and capital-light model (low capex, outsourced manufacturing) are genuine quality signals and reflect operating leverage from scale and brand mix. But the growth deceleration is concerning from an expectations standpoint: organic growth was -1% in Q3 2025; 2026 is called a 'bridge year'; and meaningful upside is deferred to 2027 (Moncler, Off-White). The embedded expectations at $108 (likely ~22-25x normalized 2025 earnings of ~$4.85 per the maintained guidance) are not egregiously optimistic but do require execution on the new license pipeline in a period of macro headwinds, tariff drag, and retail destocking. The CEO sold $1.82M in April 2026 at $91 — below current price — which is mildly negative. The 2026 bridge year framing combined with no margin of safety against a realistic base case (DCF is unusable as constructed; current price at 52-week high with zero downside cushion) argues for caution. Distribution of outcomes: bull (30% weight) — Moncler/Off-White ramp faster, tariffs resolve, 2027 growth resumes 8-10%; bear (25% weight) — license renewals become more expensive, tariff drag persists, organic growth stalls, multiple compresses to 18x; base (45% weight) — 4-6% revenue growth, 20-22% operating margins, moderate re-rating. The fat left tail is license concentration risk and licensor defection. Overall: a high-quality, capital-light franchise with a genuine but narrow moat, currently trading with expectations that are approximately fair given the 'bridge year' and without the margin of safety required across the distribution.

Key points

ROIC vs WACC spread is critically ambiguous: fact base shows 2020 ROIC of 10.1% vs WACC 9.8% (near zero spread), but 2025 financials imply dramatically higher absolute FCF (~$250M+ estimated vs $54M in 2020) suggesting a wider current spread — the data inconsistency is a key epistemic problem
The DCF intrinsic value of $28/share is rendered useless by anchoring on 2020 COVID-trough FCF with 2% growth; a properly updated model using 2025 FCF would likely yield fair value in the $80-120 range, meaning the valuation is roughly fair, not deeply cheap or expensive
Moat is real but narrow-to-moderate: capital-light licensing model, 64%+ gross margins, and demonstrated brand-building skill (Lacoste to $100M, Jimmy Choo +16%) are genuine advantages, but IPAR does not own the brands it licenses, creating structural licensor bargaining power at renewal as a moat ceiling
Expectations embedded in the price (~22-25x normalized 2025 EPS of ~$4.85) are consistent with 4-6% long-run growth and stable margins — not extreme but leaving no margin of safety if 2027 license ramp underdelivers or tariff headwinds persist
Management quality is above average: capital-light model, proactive tariff mitigation (first-sale rule, nearshoring), disciplined licensing strategy with pre-revenue pipeline (Moncler, Off-White) — but CEO insider selling at $91 in April 2026 is a mildly negative signal
2026 'bridge year' admission is candid and creditable but signals near-term earnings stagnation; organic growth -1% in Q3 2025 is below the base rate for a compounder justified at 22-25x earnings

Red flags

Fundamental data block reflects 2020 (COVID trough) financials — revenue $71.5M, ROIC 10.1%, FCF $54M — making the DCF intrinsic value of $28/share analytically useless; the near-zero ROIC/WACC spread shown is an artifact of the wrong year
IPAR does not own its core brand assets; all major licenses (Jimmy Choo, Coach, Moncler, Lacoste) are subject to renewal risk and licensor pricing power — the moat is real but borrowed rather than owned, capping long-term ROIC
Stock is trading at its 52-week high with zero downside cushion as flagged by price data (pct_below_52w_high = 0.0); the price-to-FCF of 64x (using 2020 FCF) and even normalized multiples around 22-25x leave no margin of safety across the full outcome distribution
CEO Jean Madar sold $1.82M at ~$91/share in April 2026 when stock was below current levels; insider selling near multi-year highs by the founding CEO is a modest but real signal to weigh
2027 upside thesis depends on Moncler, Off-White, and L'Enchant ramp — none of which has demonstrated revenue at scale yet; management provides no phased launch schedule, creating binary execution risk in the right tail of the distribution
Tariff headwind ($6M in Q3 2025 alone) will persist through Q1 2026 at minimum; 'first-sale rule' workaround has IT build risk and no guaranteed timeline, creating continued margin erosion not fully reflected in guidance language

Ray Dalio — 🟡 watch · 48/100 · medium confidence

IPAR is a consumer discretionary fragrance business with genuinely interesting balance sheet characteristics but meaningful macro regime vulnerabilities that a Dalio framework must stress-test carefully. On the positive side: near-zero leverage (net debt of -$159M, debt/equity of 0.019), strong current ratio (3.85x), self-funding operations with positive FCF (~$54M on 2020 base, with recent revenues at ~$1.47B scale implying far larger FCF), and significant geographic diversification via European-based operations. The company operates with a capital-light licensing model that limits capex exposure. However, serious concerns emerge across the macro regime map. The business is fundamentally a discretionary luxury/premium consumer spending play that would face material headwinds in stagflation (compressed consumer budgets + rising input costs via tariffs already evidenced at $6M/quarter) and in a deflationary deleveraging (trading down from prestige fragrances). Pricing power is constrained — management implemented only 2% price increases versus 5-7% market increases, deliberately underpricing to preserve volume, which signals limited pass-through capability under sustained inflation. The DCF intrinsic value of $28 vs. current price $107.97 represents 74% downside — the stock is priced for a regime of persistent low rates, low inflation, and uninterrupted consumer strength, exactly the single-regime dependence Dalio most fears. The fundamentals data in the fact base reflects 2020 figures (COVID year), making balance sheet assessment partially unreliable — the 10-K for 2025 shows recent quarterly revenues around $345-386M versus the $71.5M annual revenue shown, suggesting the fundamentals block is stale. This data gap reduces confidence. CEO insider selling at ~$91 (April 2026, now trading at $108) is a modest negative signal. The Moncler license and Sulfurino DTC initiative represent binary execution bets concentrated in 2027+ with no guaranteed payoff. Geographic diversification is genuine (European ops a meaningful share) and euro-denominated revenues provide some USD weakness hedge. FX dependency cuts both ways. The tariff exposure on European-manufactured goods imported to U.S. represents a structural supply chain risk that partially offsets the geographic diversification benefit. On rate sensitivity: the balance sheet is clean (virtually no debt), so direct rate sensitivity via refinancing risk is negligible — this is a genuine strength. However, valuation duration risk is very high: at 90x P/E and P/FCF of 64x on stale 2020 data (current multiples likely 20-25x on actual 2025 earnings), the stock's implied terminal value requires sustained growth that only materializes in a low-rate, high-growth regime. The All Weather lens demands holdings that survive across regimes; this one survives the balance sheet stress test but fails the valuation and pricing-power stress tests.

Key points

Near-zero leverage (D/E 0.019, net cash ~$160M) and current ratio of 3.85x provide genuine balance sheet resilience through a credit contraction — no maturity wall risk, self-funding
Geographic diversification (European operations significant share of revenue) provides partial FX hedge and reduces single-economy concentration
Capital-light licensing model means capex is minimal ($11M on 2020 base), protecting FCF even in a downturn — no heavy fixed-cost infrastructure
Travel retail +15% and emerging markets exposure create some counter-cyclical offset and geographic spread valued in a shifting world order
Tariff mitigation via first-sale rule and nearshoring shows management adaptability, though execution timing (Q2 2026) leaves 6+ months of continued drag
Q1 2026 revenue at $345M run-rate implies ~$1.4B annual scale — far above the stale 2020 fundamental data used in DCF, making valuation mechanically unreliable

Red flags

DCF intrinsic value $28 vs. $107.97 price implies 74% downside — stock is priced exclusively for a low-rate, high-growth, low-inflation regime with zero cushion for a regime shift
Pricing power is demonstrably weak under inflation: only 2% price increase implemented vs. 5-7% industry, and management signaled no further pricing — fails the inflation pass-through test
$6M quarterly tariff hit with gross margin erosion of 40-110bps confirms input cost sensitivity without adequate offset capability; European-manufactured goods face structural U.S. tariff exposure
Discretionary premium consumer demand is highly cyclical — in stagflation or deleveraging, fragrance volumes decline and trading-down accelerates (see 2020: revenue dropped from $112M to $71.5M, a -36% peak-to-trough)
CEO sold $1.82M in stock at ~$91 in April 2026, now trading at $108 — insider at current valuation lacks conviction
Fundamentals block reflects 2020 data (COVID trough year) making margin, revenue, and ratio analysis unreliable without confirmed 2025 annualized figures — significant information gap
High equity valuation (P/FCF 64x, P/E 90x on stale data) adds substantial duration risk: any rate re-pricing or growth deceleration creates severe multiple compression risk
2026 explicitly called a bridge year; Moncler and new license catalysts are 2027+ binary bets with no committed retail rollout — long-duration, unproven execution risk

Joel Greenblatt — 🔴 avoid · 32/100 · high confidence

IPAR presents a fundamental Magic Formula mismatch: it is a high-quality business (good ROIC, strong cash conversion, excellent brands) but is priced at a level that produces a deeply unattractive earnings yield on an enterprise basis. Greenblatt's framework demands BOTH high ROIC AND high earnings yield — IPAR scores well on the former but fails badly on the latter. The fact base shows 2020 EBIT of ~$70M (using operating income as proxy) against a market cap of ~$3.46B. Adjusting EV: market cap $3.46B + long-term debt $10M - excess cash (cash $170M, net debt negative ~$160M) = EV roughly $3.3B. EBIT/EV = ~$70M / $3.3B = ~2.1% earnings yield. This is extremely low — Greenblatt's Magic Formula would rank this near the bottom of any screen. On ROIC (Greenblatt's preferred denominator: net working capital + net fixed assets): current assets $601M - current liabilities $156M = net working capital ~$445M; net fixed assets are minimal for this asset-light business (capex only $11M/year suggests net PP&E well under $50M). So ROIC denominator ~$495M, EBIT ~$70M = ROIC ~14% using 2020 figures. However, the narrative confirms 2025 revenues of ~$1.47B with operating margins ~22%, implying normalized EBIT of ~$320M+ — dramatically higher than the 2020 base used in the fundamentals block, which is clearly COVID-impaired. Even using a generous $320M normalized EBIT against EV of ~$3.3B, earnings yield is only ~9.7% — borderline acceptable but the quality dimension becomes less relevant because current price at 52-week high ($108) implies the market has already priced in this quality. The DCF intrinsic value of $28/share versus current price of $108 confirms the stock trades at a massive premium to any conservative value anchor — 74% overvalued on the model. Price-to-FCF of 64x and P/S of 48x (even if based on 2020 COVID revenue, the market cap vs. 2025 revenue of $1.47B implies P/S ~2.4x which is more reasonable but still not cheap). CEO insider selling of $1.82M in April 2026 near $91 — below current price of $108 — adds caution. No special-situation catalyst present. The 'bridge year' narrative with modest growth guidance and tariff headwinds make this a fully-priced compounder, not a Greenblatt buy.

Key points

EBIT/EV earnings yield is far too low (~2% on 2020 figures; even normalized at ~9-10% using 2025 ops) to score well on Greenblatt's earnings yield axis
Business quality is genuinely high: capital-light model, strong brands (Jimmy Choo, Coach, Moncler pipeline), 64%+ gross margins, good cash conversion
Magic Formula requires BOTH axes — IPAR fails on cheapness; it is a good business at a rich price, not the 'above-average business at below-average price' Greenblatt demands
DCF intrinsic value of $28/share vs. $108 current price implies ~74% overvaluation — massive negative margin of safety
Stock is at its 52-week high with no special-situation catalyst, no spinoff, no restructuring, no forced-seller dynamic that Greenblatt exploits
Insider selling (CEO trimmed $1.82M near $91) and 'bridge year' 2026 guidance suggest limited near-term upside catalyst

Red flags

Earnings yield (EBIT/EV) approximately 2-10% depending on which revenue base used — far from the top earnings yield decile Greenblatt targets
Price-to-FCF of 64x (on 2020 FCF) is extremely expensive; even on normalized 2025 FCF it remains elevated
Zero margin of safety: stock at 52-week high, DCF says 74% overvalued, no catalyst to close any hypothetical discount
CEO Jean Madar sold $1.82M in stock at $91 in April 2026 — now trading at $108, suggesting insider did not see this level as cheap
No special situation: no spinoff, no restructuring, no rights offering, no bankruptcy emergence — the only return driver is organic compounding at a premium price
Tariff headwinds and 'bridge year' framing reduce near-term earnings power precisely when the stock appears fully priced for perfection

Stanley Druckenmiller — 🔴 avoid · 28/100 · high confidence

IPAR fails the Druckenmiller framework on nearly every dimension that matters. The forward earnings trajectory is decelerating, not inflecting upward — 2025 saw only +1% top-line growth, Q3 2025 organic sales were actually -1%, and management explicitly labeled 2026 a 'bridge year' with 'moderate growth.' The second derivative is pointing down, not up. The EPS setup is uninspiring: Q4 2025 EPS +16% YoY was a low-base beat, Q1 2026 EPS was only +2.3% YoY, and 2026 full-year guidance of $4.85 EPS implies roughly flat-to-slight growth off a softening base. This is a fundamentals deceleration story, not an inflection. Tape confirmation is also absent: the stock sits at its 52-week high as of data date ($107.97), but the 52-week range is $77.21–$139.94, meaning the stock is well below its prior highs and sitting at the bottom of its recent recovery — not making new highs in a leadership sense. Price/sales of 48x on 2020 revenue data (the fundamentals block appears stale at 2020 figures; actual 2025 revenue ~$1.47B implies P/S ~2.3x, which is more reasonable) and P/E ~90x trailing on 2020 earnings are distorted by stale data, but the real-time picture from Q1 2026 EPS of $1.35 and full-year guidance of $4.85 puts the forward P/E around 22x — not obviously cheap but not a valuation catalyst. The DCF intrinsic value of $28 vs. $108 current price signals massive multiple compression risk if growth disappoints. The macro/liquidity angle provides no edge: IPAR has no meaningful Fed sensitivity or rate-cycle leverage — it's a consumer discretionary/luxury fragrance licensor whose micro-drivers (license ramp, tariff mitigation, retailer destocking) are idiosyncratic and timing-uncertain. The Moncler $100M opportunity is 3–5 years out with no phase-in detail — not the 12-18 month catalyst the Druckenmiller framework demands. CEO Jean Madar sold $1.82M in shares at ~$91 in April 2026 — insider conviction is moving the wrong direction. The position lacks the asymmetry required for concentrated sizing: the bull case (Moncler ramp, 2027 licenses, tariff resolution) is a 2027+ story with execution risk, while the bear case (continued organic deceleration, margin erosion, retailer destocking) could pressure near-term numbers meaningfully. There is no 'why now' catalyst within 6-18 months that the market hasn't already partially discounted.

Key points

Forward earnings direction is decelerating: 2025 organic growth flat to negative in Q3; 2026 guidance flat to modest growth; second derivative turning down
Management explicitly called 2026 a 'bridge year' — no near-term earnings inflection to trade off
No macro/Fed tailwind angle; IPAR is a micro-driven consumer story with no liquidity cycle leverage
Stock is well below its $139.94 52-week high despite 'good' results — tape is not confirming any bullish fundamental thesis
Main upside catalyst (Moncler $100M, Off-White/L'Enchant launches) is a 2027+ story — too far out for a Druckenmiller-style 12-18 month conviction trade
CEO insider selling $1.82M at ~$91 in April 2026 — insiders not buying the dip
DCF intrinsic value $28 vs. $108 market price: massive multiple compression risk embedded
Tariff headwinds persist through at least Q1 2026; first-sale rule workaround not implemented until Q2 2026

Red flags

Fundamental deceleration confirmed: organic Q3 2025 -1%, full year 2025 only +1% top line, Q1 2026 only +2.3% YoY EPS growth
Explicit management guidance language 'bridge year' and 'moderate growth' — forward estimates not rising
Tape below 52-week high by ~23% ($107.97 vs $139.94 high) — relative weakness, not leadership
CEO sold $1.82M in stock near recent lows (~$91) before stock recovered — insider not a buyer
No identifiable near-term catalyst (6-18 months) that market hasn't already considered
Moncler/Off-White/L'Enchant upside is 2027+ execution story — no timing edge
Tariff erosion on gross margins ongoing with limited pricing power beyond 2% implemented
Retail destocking dynamic (sell-in lagging sell-out by 2+ pts) suppressing near-term revenue visibility

Bruce Greenwald — 🔴 avoid · 28/100 · medium confidence

Interparfums is a genuine operating business with a real earnings history, so the EPV framework applies directly. However, the market price is deeply disconnected from any EPV-anchored valuation, and the DCF itself — which is more generous than EPV — already signals 74% overvaluation at $107.97 vs. $28.04 intrinsic.

EPV construct: The fact base shows 2020 financials as the most recent normalized data (revenue $71.5M, FCF $54M, NOPAT implied ~$48M after rough tax-adjustment from $38M net income with ~$70M operating income). However, the narrative confirms this is stale — Q1 2026 revenues alone were $345M, implying full-year revenue run-rate approaching ~$1.4-1.5B. The fundamentals block appears to reflect 2020 pandemic-year data, which drastically understates current earnings power. Using management's 2026 guidance of $1.48B sales and $4.85 EPS on ~32M shares = ~$155M net income. Operating income would be roughly $1.48B × 22% margin = ~$325M. Applying a 25% tax rate gives NOPAT ~$244M. Capitalizing at WACC of 9.82% yields EPV of roughly $2.49B enterprise value. Adding net cash (~$160M) gives equity value ~$2.65B, or ~$83/share. At $108, the stock trades ~30% above this EPV estimate — meaning the market is paying for growth, not just current earnings power.

Moat assessment: IPAR's barriers are real but not ironclad. They hold licensed fragrance rights for premium brands (Jimmy Choo, Coach, Lacoste, Mont Blanc, Moncler) — these are contractual rather than proprietary, meaning the moat depends on license renewal and brand owner decisions, not IPAR's own competitive advantage. Customer captivity is indirect (consumers buy the brand, not IPAR). Economies of scale exist in formulation, sourcing, and distribution, but competitors like Coty, Givaudan, and IFF can replicate these at scale. EPV modestly exceeds what a reproduction-value estimate would suggest (given limited tangible asset intensity — this is capital-light), implying some franchise value, but it is not overwhelming.

The DCF's 2% growth assumption anchored to 2020 revenue CAGR is severely distorted — actual revenues have grown dramatically since 2020. The DCF is essentially useless as constructed. Even my corrected EPV at ~$83/share suggests the stock is modestly expensive. The bull case requires paying for Moncler ramp, Off-White, Sulfurino DTC, and new licenses — all speculative growth inside a moat that is contractually contingent rather than structural. CEO insider selling at ~$91 is a mild negative signal. '2026 as a bridge year' with organic growth near zero undermines any near-term EPV expansion argument.

Key points

EPV estimate using current earnings power (~$4.85 EPS guidance, ~22% operating margin on $1.48B) yields intrinsic value of approximately $75-85/share — stock at $108 trades ~25-40% above EPV
Moat is real but contractually contingent: license agreements are the value source, not proprietary process or deep consumer captivity — licenses can be lost or expire
The provided DCF ($28/share intrinsic) is distorted by 2020 pandemic revenue base and 2% growth assumption; normalized EPV is far higher but still below market price
Capital-light model (low capex, high FCF conversion) supports franchise characteristics, but reproduction cost of the asset base is relatively low given limited proprietary IP
License pipeline (Moncler, Off-White, L'Enchant) represents speculative growth that cannot be credited in EPV framework — market appears to be paying for it already
Balance sheet is pristine: ~$188M cash, minimal debt, current ratio ~3.8x — provides downside cushion but doesn't close the valuation gap

Red flags

Market price ~30-40% above normalized EPV — the gap is explained only by growth assumptions for unproven license ramp-ups
Contractual (not structural) moat — license non-renewal would destroy franchise value rapidly; no permanent barrier
CEO sold $1.82M in shares near $91 in April 2026, suggesting insiders do not see significant upside from current levels
2026 explicitly characterized as 'bridge year' with near-zero organic growth — EPV is not expanding in the near term to justify premium
DCF provided in fact base is badly miscalibrated (2020 base FCF, 2% growth) and cannot be used as a reliable anchor — reduces confidence in any model-based valuation
Retail sentiment is speculative (options traders targeting 50-75% ROI calls) — suggests price may be partially supported by momentum and sentiment rather than fundamentals

Peter Lynch — 🔴 avoid · 28/100 · high confidence

Interparfums is an understandable, asset-light consumer brand licensor — I can explain it in one sentence: IPAR licenses prestige fragrance brands (Jimmy Choo, Coach, Lacoste, Montblanc) and sells them globally through department stores, travel retail, and e-commerce. The business model is visible, the cash generation is real, and the balance sheet is clean. However, the PEG is deeply problematic. The fundamentals data reflects 2020 (COVID trough), so I'm anchoring valuation analysis on current trading realities. At $108/share, the stock trades at roughly 22x forward EPS guidance of $4.85 — that's manageable on its own. But the critical question is: what's the growth rate? Revenue CAGR is listed as -13% (a 2-year figure contaminated by COVID), and current organic growth is running at roughly 1-3% in 2025-2026. Even being generous and assuming 8-10% EPS growth through 2026-2027 driven by new licenses (Moncler, Off-White), the PEG comes out near 2.2-2.75x — well above my 1.0 threshold and approaching 'poor' territory. The category classification matters here: IPAR is a stalwart at best, not a fast grower. Q3 2025 organic sales were -1%; Q1 2026 was +1.8% YoY with EPS up only 2.3%. Management explicitly called 2026 a 'bridge year.' That's stalwart-to-slow-grower language, not fast grower language. For a stalwart, I'd want to buy at 30-40% upside to fair value and sell at 50% gain — but the DCF intrinsic value of $28/share (even if the DCF is flawed due to using 2020 base FCF) signals extraordinary overvaluation. Even doubling the FCF to reflect 2024-2025 levels (~$200M+ range), the stock still trades at a premium. The price-to-sales of 48x (using 2020 revenue — misleadingly high) and a more realistic P/S near 2.3x on current ~$1.47B revenue is less alarming, but the P/E of 22x on 2-3% growth is still a PEG disaster. CEO insider selling 20,000 shares at $91 in April 2026 is a yellow flag — insiders are sellers, not buyers. Institutional coverage is light (good) but the stock is at its 52-week high (bad — no neglected-stock edge). New licenses (Moncler especially) are genuine optionality, but 3-5 year ramp with no phase-in schedule is speculative. The tariff headwind is real and eating into margins through at least Q1 2026. Inventory management is improving (down 6% YoY). Balance sheet is genuinely strong: minimal long-term debt ($10M), $169M+ cash, current ratio near 3.8 — this is the one area I applaud. But a clean balance sheet doesn't fix a PEG of 2.5. For Lynch investors: this is a great business at a poor price, in a bridge year, with the CEO selling. Pass.

Key points

Category: Stalwart at best — organic revenue growth 1-3% in 2025-2026; EPS growth ~2-16% in recent quarters but guided to moderate for full year 2026 at $4.85 EPS
PEG deeply unfavorable: ~22x forward P/E divided by even optimistic 8-10% growth rate yields PEG of 2.2-2.75x — well above my 1.0 ceiling
Business is explainable in one sentence: licenses prestige fragrance IP, sells through department stores and travel retail globally — high marks for understandability
Balance sheet is excellent: minimal debt (~$10M LT debt), $169M+ cash, current ratio ~3.8, capital-light model with 64%+ gross margins
New licenses (Moncler, Off-White, L'Enchant) are genuine optionality but 3-5 year ramp is speculative and unproven at scale
Travel retail +15% YTD and Coach/Jimmy Choo +16% show some bright spots within the portfolio
Inventory down 6% YoY — improving composition, finished goods mix better — no inventory pile-up warning

Red flags

PEG ~2.5x using realistic forward growth assumptions — textbook 'overpaying for the best company and still losing money' scenario
2026 explicitly called a 'bridge year' by management — stalwart language, not fast-grower language; organic growth -1% in Q3 2025
CEO Jean Madar sold 20,000 shares at ~$91 in April 2026 ($1.82M) — insiders are selling, not buying
Stock at or near 52-week high ($107.97 equals the listed 52-week high) — no neglected-stock edge, no margin of safety discount
DCF intrinsic value ($28 base, $34 bull) implies massive overvaluation even accounting for 2020 base FCF conservatism
Tariff headwind ($6M hit in Q3 alone) eroding gross margins; first-sale rule workaround not live until Q2 2026 at earliest
Montblanc 'dipping' per narrative — innovation fatigue risk in a key legacy brand; Moncler ramp is 3-5 years away with no committed phase-in schedule

Valuation Referee (Damodaran-style) — 🔴 avoid · 22/100 · high confidence

The DCF model supplied by the fact base uses 2020 financials (revenue $71.5M, FCF $53.98M) as its base, which is deeply stale — actual 2025 revenue is approximately $1.47B and Q1 2026 alone generated $345M in sales. This creates a catastrophic base-case error: the model's intrinsic value of $28.04/share is derived from a COVID-year trough FCF that is roughly 20x smaller than current run-rate earnings. Correcting for this is essential before any valuation judgment. Using more current data: 2025 full-year EPS guidance of $5.12 and management's 2026 guidance of $4.85 EPS on $1.48B in sales implies a current-year FCF in the range of $150-180M (applying historical ~65-75% FCF margins to recent earnings). At the current price of $107.97 with ~32M shares outstanding, the market cap is ~$3.46B. Net cash is approximately $160-190M (as of late 2025 based on the $188M cash position cited in Q3 2025), implying enterprise value of roughly $3.27B. Against a normalized FCF of ~$155M (midpoint estimate), the EV/FCF multiple is approximately 21x. Now reverse-engineering what the market expects: to justify $107.97/share under a two-stage DCF with WACC ~9.8% (as given, which is reasonable given beta 1.1, though slightly generous for a consumer staples-adjacent name), the market needs FCF to grow at roughly 10-12% annually for 10 years and then persist at 3% terminal growth. Is that achievable? IPAR's recent growth has been decelerating sharply: 2025 organic sales effectively flat (-1% Q3), 2026 explicitly flagged as a 'bridge year' with 'moderate' growth, revenue CAGR over 2018-2020 was negative due to COVID but pre-COVID growth was strong. The forward 2026 guidance of $1.48B in sales with $4.85 EPS represents only ~1% top-line growth and ~5% EPS decline from 2025. The implied market expectation of 10%+ sustained FCF growth for a decade is heroic given: (1) management's own guidance of flat-to-modest growth through 2026-2027, (2) tariff headwinds eroding gross margins by ~40-50 bps/quarter, (3) key brand saturation (Mont Blanc declining), (4) retail destocking reducing sell-in, (5) 2027 recovery contingent on unproven new licenses (Moncler, Off-White, L'Enchant). On quality of growth: ROIC per the fact base is only 10.1% (2020 data, likely higher now given scale) versus WACC of ~9.8% — only marginally value-creating, and any acceleration in reinvestment for new licenses/Sulfurino boutiques could compress returns below cost of capital. The capital-light model is real (low capex at ~$11M) but the business requires ongoing license fees and marketing spend that are partly captured in operating costs. Price-to-sales of 48x (per fundamentals block, again reflecting stale 2020 revenue) is nonsensical; using 2025 actual $1.47B revenue the ratio is approximately 2.4x — reasonable. P/E of ~22x on 2026E $4.85 EPS is the more honest multiple; price-to-FCF of roughly 21-22x on normalized FCF. These multiples are not extreme for a high-margin consumer brand franchisor, but they price in a recovery trajectory that management itself is not guiding to until 2027+. The CEO sold $1.82M in stock at ~$91 in early April 2026; the stock has since risen to ~$108, now sitting at its 52-week high — there is zero margin of safety. Under conservative assumptions (FCF growth 4-5% for 5 years reflecting management's own 'moderate' guidance, then 2.5% terminal), I estimate intrinsic value at roughly $70-80/share. Under a base case allowing 7% FCF growth (achievable if Moncler and 2027 licenses perform), intrinsic value reaches ~$90-95. The current price of $107.97 only works in a bull scenario (10%+ sustained growth) that requires heroic execution on multiple unproven licenses and a rapid tariff resolution. At the 52-week high with no margin of safety, the risk-reward is asymmetrically negative from a Damodaran perspective.

Key points

The provided DCF uses 2020 trough FCF ($54M) as base — rendering the $28.04 intrinsic value meaningless; actual 2025 run-rate FCF is ~$150-170M, yielding a corrected EV/FCF of ~21x
Reverse-engineering $107.97 requires 10-12% sustained FCF CAGR for a decade — inconsistent with management's own 'bridge year' 2026 guidance and flat organic growth in 2025
ROIC (~10%) barely exceeds WACC (~9.8%), meaning growth adds only marginal value; new license reinvestment (Moncler, Sulfurino boutiques) could temporarily push ROIC below cost of capital
Conservative DCF (4-5% FCF growth, 2.5% terminal) yields intrinsic value ~$70-80; base case (7%) ~$90-95; current price of $108 requires the optimistic scenario just to break even
WACC of 9.82% is defensible given beta 1.1 and sector risk, though a slight premium for tariff/FX/execution risk could push it to 10.5%, further compressing intrinsic value by ~$10-15/share
Stock at 52-week high, CEO sold $1.82M near $91; no margin of safety at current price

Red flags

Price implies heroic 10%+ annual FCF growth for decade — contradicted by management's own 'moderate growth' and 'bridge year' language for 2026
Zero margin of safety: trading at 52-week high ($107.97 = 52w high), requiring optimistic scenario to justify even fair value
CEO insider selling of 20,000 shares in April 2026 near $91 — stock has since risen further, making valuation case even weaker
Tariff headwinds ($6M Q3 2025 hit, continuing through Q1 2026) and retail destocking suppress near-term FCF, yet price embeds recovery that hasn't materialized
2027 growth thesis depends on three new unproven licenses (Moncler, Off-White, L'Enchant) — execution risk is high and timeline is vague ('3-5 years' for Moncler to reach $100M)
Mont Blanc saturation and U.S. segment organic declines (-5% Q3, -6% YTD) signal portfolio aging at the core while new brands are unproven at scale

Benjamin Graham — 🔴 avoid · 22/100 · high confidence

Interparfums fails the Graham value framework on nearly every quantitative criterion. The most decisive disqualifier is valuation: the DCF intrinsic value is $28.04/share (bear $25.28, bull $34.09) against a current price of $107.97 — implying a 74% overvaluation relative to discounted cash flows, with zero margin of safety. The stock is trading at a P/E of ~90x (trailing 2020 earnings; even on normalized 2025 EPS of ~$5.12, the implied P/E is roughly 21x, still above Graham's 15x defensive cap), price-to-book of 6.45x, and price-to-sales of 48.36x. Graham's P/E × P/B composite stands at approximately 90 × 6.45 = 580, massively exceeding his 22.5 ceiling. The earnings yield of 2.12% is well below high-grade bond yields, offering no risk compensation. On the asset side, the balance sheet is actually quite sound: current ratio of 3.85 (above the 2.0 threshold), long-term debt of only $10M against net current assets of ~$444M, and a strong cash position of $170M. These are genuine positives. However, the NCAV (current assets $601M minus ALL liabilities ~$199M = ~$402M / 32M shares = ~$12.50/share) is far below the $108 stock price — no net-net opportunity exists. Revenue declined 13% CAGR over the reported 2-year period (pandemic distortion), and while multi-year net income history (2016-2020) shows consistent profitability, the fact base covers only five years of complete data, falling short of Graham's preferred 10-year earnings stability window. The fundamentals data is anchored to fiscal year 2020 — a COVID-impacted year — making the reported operating margin of 98% and FCF margin of 75% anomalous and unreliable for conservative appraisal. More recent results (Q1 2026: $345M revenue, EPS $1.35) suggest a much larger, more profitable business than the 2020 snapshot implies, but the key point remains: the stock is priced for a high-growth future, not a Graham margin-of-safety purchase. CEO insider selling of 20,000 shares at ~$91 (April 2026) while the stock now trades at ~$108 — at the 52-week high — is a further cautionary signal under Mr. Market discipline. The business quality is respectable (strong brands, low debt, good cash generation), but quality does not substitute for price adequacy under Graham's doctrine.

Key points

DCF intrinsic value of $28.04/share implies 74% overvaluation at $107.97 — no margin of safety
P/E × P/B composite vastly exceeds Graham's 22.5 ceiling; earnings yield of 2.12% is below bond yields
Balance sheet is genuinely strong: current ratio 3.85, minimal long-term debt ($10M), large cash buffer ($170M)
NCAV approximately $12.50/share — stock trades at 8.6x net current asset value, not remotely a net-net
Consistent profitability demonstrated (2016-2020 all profitable), but only 5 years of complete data vs. Graham's 10-year standard
Fundamentals anchored to COVID-impacted FY2020, reducing reliability of reported margins and FCF for conservative appraisal
CEO sold 20,000 shares at ~$91 in April 2026; stock now at 52-week high of $108 — insider not a buyer at these levels

Red flags

Price 285% above DCF bull-case intrinsic value ($34.09) — no conceivable margin of safety under any conservative assumption
P/E of ~21x on normalized 2025 EPS exceeds Graham's 15x defensive ceiling; trailing P/E of 90x is extreme
P/B of 6.45x combined with elevated P/E produces composite far exceeding Graham's 22.5 rule
Stock is at its 52-week high with zero discount from market optimism — Graham would demand a pessimistic market price
Revenue CAGR of -13% over the reported period (COVID-distorted) raises questions about earnings growth track record
CEO insider selling near current price levels is a negative signal under Mr. Market discipline
DCF growth assumption of 2% (matching revenue CAGR) may actually be generous given near-term 'bridge year' guidance

Howard Marks — 🔴 avoid · 22/100 · high confidence

IPAR is a high-quality business — strong brands, capital-light model, 64%+ gross margins, minimal debt — but Howard Marks' framework begins and ends with price relative to value, not quality in the abstract. The DCF is damning: intrinsic value estimated at $28/share base ($34 bull), against a current price of $107.97. That represents a 74% premium to the bull case. At P/E ~90x (on 2020 earnings), P/FCF ~64x, and P/S ~48x (again, 2020 base), optimism is not partially priced in — it is grotesquely priced in. The fundamental fact base appears anchored to 2020 (a COVID-depressed year), so the DCF's 2% FCF growth assumption from a trough base is structurally charitable and still yields a massive downside. More recent data confirms revenue has recovered substantially (Q1 2026 $345M, FY guidance $1.48B), but even on a normalized ~$1.48B revenue run rate, the $3.46B market cap implies a price-to-sales of ~2.3x — which looks less obscene, yet operating margins of ~22%, FCF conversion high — perhaps $220-250M normalized FCF — still puts price-to-FCF around 14-16x, which for a slow-growth (~1-2% organic) fragrance licensor carries little margin of safety. Management itself labeled 2026 a 'bridge year' with 'moderate' growth; 2027 upside is contingent on unproven license ramps (Moncler, Off-White). The CEO sold $1.82M in stock at ~$91 in April 2026; the stock is now near its 52-week high at $108. Sentiment is cautiously bullish, not panicked or revulsed — there is no forced-selling dynamic, no capitulation, no fear in the price. The pendulum is nowhere near fear. Balance sheet is genuinely strong (current ratio 3.8x, net cash ~$160M, minimal LTD), which prevents a distressed/fragility flag — but low leverage only matters when you're getting it cheaply. Paying 90x earnings for a licensor facing tariff headwinds, retail destocking, and organic stagnation is the opposite of the Marks framework: you are buying a perceived safe, high-quality 'can't-lose' story at peak popularity, with all good news embedded and a low bar nowhere in sight. The only scenario where this works is a rerating higher on Moncler/2027 execution — a single-outcome dependency Marks explicitly avoids.

Key points

DCF intrinsic value of $28/share (base) to $34 (bull) vs. $107.97 current price — 74% downside to the bull case; no margin of safety whatsoever
Price embeds flawless execution: P/E ~90x, P/FCF ~64x on trough 2020 data; even on normalized FY2026 guidance (~$1.48B revenue), multiples remain elevated for a slow-growth licensor
Balance sheet is genuinely strong (net cash ~$160M, current ratio 3.8x, debt/equity 0.02) — this is a structural positive but irrelevant when the price already over-compensates for quality
Organic growth is stalling: Q3 2025 organic sales -1%; 2025 full-year +1%; 2026 explicitly a 'bridge year' — the business is flat-to-decelerating while priced for sustained compounding
New license upside (Moncler, Off-White) is a 2027+ binary bet on unproven execution; single-outcome dependency is Marks' cardinal sin
Sentiment is cautiously bullish, not revulsed — no forced selling, no capitulation, no fear priced in; the pendulum is not swinging toward fear
CEO insider selling at ~$91 (April 2026) while stock now at $108 (near 52-week high) signals insider conviction is lower than street enthusiasm

Red flags

Optimism fully priced in: trading near 52-week high with 0% below peak; P/FCF 64x and P/S 48x (on depressed 2020 base) signal peak popularity pricing
74% downside to bull-case DCF intrinsic value — no margin of safety, asymmetric downside NOT upside
CEO sold $1.82M in shares in April 2026; management's own revealed preference contradicts the bull case
2026 'bridge year' admission from management: growth flatlines exactly when multiple demands perfection
Tariff margin erosion ($6M Q3 2025 impact) persisting through at least Q1 2026 — guidance absorbs this but upside is thin
Single-outcome dependency: meaningful upside requires successful ramp of three new unproven licenses by 2027 — precisely the kind of rosy forecast Marks penalizes
No variant view available to a contrarian — the bull case (great brands, capital-light, long-term growth) is the obvious first-level consensus; buying here offers no analytical edge

Seth Klarman — 🔴 avoid · 18/100 · high confidence

IPAR fails the Klarman value test on every material dimension. The DCF model — using a depressed 2020 base FCF of ~$54M growing at 2% — yields an intrinsic value of ~$28/share against a current price of ~$108, implying ~74% downside. Even in the bull scenario the model yields only $34/share. The market is pricing the business at ~90x trailing P/E, ~64x price-to-FCF, and ~48x price-to-sales on stale 2020 data. Using the more current Q1 2026 run-rate ($345M quarterly sales, ~$1.48B full-year guidance, $4.85 EPS guidance), a normalized earnings basis is more favorable, but the stock still trades at ~22x forward earnings — not cheap for a company guiding to 'moderate growth' in a 'bridge year.' There is no margin of safety. The business is fine — capital-light, high gross margins (~64%), pristine balance sheet (current ratio ~3.8, minimal long-term debt, $169M+ cash) — but being a good business at a fair or premium price is not a Klarman buy. Value rests entirely on continued brand licensing momentum, Moncler ramp ($100M in 3-5 years, no hard commitments), and 2027 license launches — all optimistic forecasts, none stress-testable against a hard asset floor. The CEO sold $1.82M in stock in April 2026 near $91; the stock is now at $108, at or near its 52-week high. There is no forced selling, no orphaned complexity, no catalyst that locks in value below current price. Liquidation value is unclear but likely far below market price given the intangible-heavy business (brand licenses, relationships). The balance sheet safety is genuinely good, but that merely limits the catastrophic tail — it does not create a margin of safety at current prices. The DCF is severely handicapped by using 2020 COVID-impacted base FCF; even adjusting to current ~$53M (from the most recent data shown), the 2% growth assumption is conservative versus recent performance, but the stock's price still reflects a massive growth premium the conservative framework cannot support. Cash is the appropriate alternative.

Key points

DCF intrinsic value ~$28/share (bull $34) vs. $108 current price — 74% implied downside with no margin of safety
Balance sheet is genuinely clean: low debt, ~$170M+ cash, current ratio ~3.8 — but financial strength alone does not create a value opportunity at these prices
Business quality is high (64%+ gross margins, capital-light licensing model, diversified brand portfolio) but quality without discount is not a Klarman buy
2026 explicitly described as a 'bridge year' with moderate growth; meaningful upside contingent on unproven Moncler ramp and 2027 license launches — classic speculative growth dependency
CEO insider selling 20,000 shares at ~$91 in April 2026 while stock now trades at $108 — not alarming in isolation but not encouraging for a thesis requiring long-term management alignment
No special situation, no forced selling, no complexity premium, no catalyst that locks in value — exactly the conditions Klarman would hold cash rather than deploy capital
P/E ~90x (2020 basis), ~22x forward (2026 guidance) — even on generous forward earnings, premium pricing for a company with decelerating organic growth (-1% Q3 2025 organic)

Red flags

No margin of safety at any plausible conservative valuation — even bull-case DCF shows 68% downside from current price
Thesis requires growth optimism: Moncler catalyst ($100M/3-5 years), new license rollouts, Sulfurino DTC — all speculative, none asset-backed
Organic revenue growth stalled: Q3 2025 organic -1%; 2020 revenue base used in DCF shows -13% 2-year CAGR; 'bridge year' framing for 2026 signals continued deceleration
CEO sold stock at $91 in April 2026 — now at $108, suggesting insiders do not see current price as undervalued
Intangible-heavy business (brand licenses, relationships) means liquidation value would be a fraction of book value, destroying the downside floor
Stock trading at 52-week high ($107.97 = 52w high per price data) — no technical dislocation, no panic selling, no forced seller creating opportunity
Tariff headwinds ($6M Q3 hit) with first-sale rule workaround not live until Q2 2026 — near-term margin erosion unresolved

Walter Schloss — 🔴 avoid · 18/100 · high confidence

IPAR fails virtually every Schloss criterion. The stock trades at $107.97, which is at its 52-week high per the price data (52W high = $107.97, pct_below_52w_high = 0.0%) — the precise opposite of a Schloss bargain. Price-to-book is 6.45x, far above tangible book. The DCF intrinsic value is $28.04/share vs. the $107.97 market price, implying 74% downside — a stark reminder that even on generous cash-flow terms, the stock is deeply overvalued. Price-to-sales at 48.36x and P/E at 90x are luxury multiples for a consumer products licensor, not statistical bargain territory. The balance sheet is actually decent (current ratio 3.85x, long-term debt only $10M, net cash ~$160M), which is a Schloss positive, but it is overwhelmed by the extreme valuation. Stockholders' equity of $536M vs. market cap of $3.46B means the market is paying roughly 6.5x book — Schloss would require a discount to book, not a 550% premium. The fundamental data in the fact base appears to be from 2020 (revenue $71.5M, net income $38M), which is severely stale — by 2026, Q1 revenues alone were $345M — yet even updating for current scale doesn't change the valuation picture. Insider selling (CEO sold $1.82M in April 2026) is a Schloss negative. Revenue CAGR is negative (-13% over the reported 2-year window), though this reflects COVID distortions. The business is asset-light (licensing model), meaning tangible asset coverage is minimal relative to enterprise value. The investment thesis is entirely earnings/brand/growth narrative driven, not asset-backed — everything Schloss avoided.

Key points

Stock is AT its 52-week high ($107.97), not near a multi-year low — opposite of Schloss entry criterion
Price-to-book of 6.45x represents a massive premium to net tangible assets; Schloss required discounts to book
DCF intrinsic value of $28.04/share vs. $107.97 market price implies 74% overvaluation even on generous FCF assumptions
Balance sheet quality is good (net cash ~$160M, minimal LTD of $10M, current ratio 3.85x) — the one Schloss positive
Market cap of $3.46B vs. stockholders' equity of $536M = 6.45x book; no margin of safety in assets whatsoever
Asset-light licensing model means tangible assets are minimal; value entirely in intangible brand licenses and goodwill

Red flags

Trading at 52-week high — Schloss never bought what was rising and in favor
Price-to-book 6.45x — far above Schloss's threshold; no asset-based margin of safety
CEO Jean Madar sold $1.82M in stock at ~$91 in April 2026 — insider selling is a Schloss negative
Investment thesis is 100% dependent on growth narratives (Moncler, new licenses, DTC expansion) — not verifiable assets
P/E of 90x and P/Sales of 48x reflect pure growth premium; Schloss required absolute cheapness, not relative cheapness
License-driven business model is complex and dependent on third-party brand relationships that cannot be independently appraised as hard assets
Fundamental data in fact base is 2020-vintage, creating opacity about current book value per share

Fact base appendix

Price

last_close: 107.97
as_of: 2026-06-28
high_52w: 107.97
low_52w: 107.97
pct_below_52w_high: 0.0

Fundamentals

last_price: 107.97
market_cap: 3457823457
fifty_two_week_high: 139.94
fifty_two_week_low: 77.21
beta: 1.1071802
currency: USD
exchange: NASDAQ NMS - GLOBAL MARKET
sector: Consumer products
industry: Consumer products
price_source: finnhub
bars: 1
entity: INTERPARFUMS, INC.
fiscal_year: 2020
revenue: 71500000
revenue_period: 2020-12-31
net_income: 38219000
net_income_period: 2020-12-31
operating_income: 70083000
operating_income_period: 2020-12-31
operating_cash_flow: 64993000
operating_cash_flow_period: 2020-12-31
capex: 11011000
capex_period: 2020-12-31
total_assets: 890145000
total_assets_period: 2020-12-31
current_assets: 600720000
current_assets_period: 2020-12-31
current_liabilities: 156205000
current_liabilities_period: 2020-12-31
stockholders_equity: 535835000
stockholders_equity_period: 2020-12-31
cash_and_equivalents: 169681000
cash_and_equivalents_period: 2020-12-31
long_term_debt: 10136000
long_term_debt_period: 2020-12-31
shares_outstanding: 32071785
operating_margin: 0.9802
net_margin: 0.5345
roe: 0.0713
debt_to_equity: 0.0189
current_ratio: 3.8457
roic: 0.1014
free_cash_flow: 53982000
fcf_margin: 0.755
pe_ratio: 90.47
price_to_fcf: 64.06
price_to_sales: 48.36
revenue_cagr: -0.1329
revenue_cagr_years: 2
fundamentals_source: edgar_companyfacts
price_to_book: 6.45
earnings_yield: 0.0212

Filings reviewed

8-K (2026-05-13) https://www.sec.gov/Archives/edgar/data/822663/000175392626000860/ipar-20260508.htm
8-K (2026-05-05) https://www.sec.gov/Archives/edgar/data/822663/000175392626000773/ipar-20260505.htm
10-Q (2026-05-05) https://www.sec.gov/Archives/edgar/data/822663/000175392626000771/ipar-20260331.htm
10-K (2026-03-10) https://www.sec.gov/Archives/edgar/data/822663/000175392626000464/ipar-20251231.htm
10-Q (2025-11-05) https://www.sec.gov/Archives/edgar/data/822663/000175392625001703/ipar-20250930.htm
10-K (2025-03-11) https://www.sec.gov/Archives/edgar/data/822663/000175392625000424/ipar-20241231.htm

Other sources

[news] Interparfums Inc (IPAR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
[news] Interparfums Inc (IPAR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
[news] Interparfums: A Fine Fragrance Machine, But 2026 Is A Bridge Year (NASDAQ:IPAR) - Seeking Alpha
[news] Interparfums: Capital-Light Model Positions Stock For Growth Despite Near-Term Headwinds - Seeking Alpha
[news] Coach and Roberto Cavalli helped lift Interparfums Q1 sales to $345M - Stock Titan
[news] Interparfums Inc (IPAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
[news] Is Interparfums, Inc. (IPAR) A Good Stock To Buy Now? - Yahoo Finance
[news] Perfume maker Interparfums keeps 2026 forecast after $345M quarter - Stock Titan
[news] GW Henssler & Associates Ltd. Sells 22,841 Shares of Interparfums, Inc. $IPAR - MarketBeat
[news] IPAR Forecast — Price Target — Prediction for 2027 - TradingView
[news] Is Interparfums, Inc. (IPAR) A Good Stock To Buy Now? - Yahoo Finance
[news] Interparfums Readies for Q1 Earnings: Key Insights for Investors - Yahoo Finance
[news] Interparfums, Inc. Actuals & Estimates (NASDAQ:IPAR) - TradingView
[news] Inter Parfums (NASDAQ: IPAR) CEO entity trims 20,000 shares - Stock Titan
[news] Interparfums CEO Jean Madar sells $1.82 million in stock - Investing.com
[discussion] $IPAR Share Price: $92.74

Contract Selected: Nov 20, 2026 $100 Calls

Buy Zone: $2.55 – $3.15 Targe

[discussion] Wall St is expecting 0.94 EPS for $IPAR Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/ipar?
[discussion] $IPAR Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.35 up 2.27% YoY • Reported

[discussion] $IPAR Current Stock Price: $90.47 Contracts to trade: $90.0 IPAR May 15 2026 Call Entry: $8.00 Exit:
[discussion] #INSIDERS $ANVS Director bought 713,800 shares at $2.10 worth approximately $1499K (transaction dat
[discussion] Wall St is expecting 1.23 EPS for $IPAR Q1 [Reporting 05/11 BMO] http://www.estimize.com/intro/ipar?
[discussion] $IPAR shines with a record Q4, but what's next in 2026? 💡

Earnings of 88 cents beat the Zacks

[discussion] $IPAR just beat Q4 estimates — and the growth story is still intact 🚀

Sales rose 7%, organic growth

[discussion] $IPAR Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.88 up 15.79% YoY • Reported

[discussion] $IPAR reports after the close, Estimize Consensus +0.06 EPS and +1.76M Revs compared to WS http://ww
[discussion] $IPAR Share Price: $103.19

Contract Selected: Aug 21, 2026 $100 Calls

Buy Zone: $6.80 – $8.40 Targ

[discussion] $IPAR setting up for a classic push-pull quarter.

Fourth-quarter results are likely to reflect gain

[discussion] $IPAR poised for an earnings beat despite headwinds! 🚀

Interparfums' strength in its brands and

[discussion] $HSY $EAT $MOV $IPAR $ABNB — Valentine’s Day could spark more than romance… it could spark profits 💘
[discussion] Wall St is expecting 1.17 EPS for $IPAR Q1 [Reporting 05/11 BMO] http://www.estimize.com/intro/ipar?
[earnings_call] Interparfums, Inc IPAR Q3 2025 Earnings Call

Generated 2026-07-17T20:16:25 · est. cost $1.48

What each investor thinks

AI & Disruption Referee (Christensen-style) Referee

pass · 78

Terry Smith (Fundsmith) Quality

watch · 58

Warren Buffett Quality

watch · 55

Chuck Akre Quality

watch · 52

Philip Fisher Growth

watch · 52

Charlie Munger Quality

watch · 52

Fourth, CEO selling 20,000 shares at ~$91 in April 2026 is a mild negative signal, though not alarming at a founder-led company.

Forensic Short-Seller (Chanos/Einhorn-style) Referee

watch · 52

Michael Mauboussin Quality

watch · 52

Ray Dalio Risk

watch · 48

Joel Greenblatt Value

avoid · 32

Stanley Druckenmiller Risk

avoid · 28

Bruce Greenwald Value

avoid · 28

Peter Lynch Growth

avoid · 28

Valuation Referee (Damodaran-style) Referee

avoid · 22

Benjamin Graham Value

avoid · 22

Howard Marks Risk

avoid · 22

Seth Klarman Value

avoid · 18

Walter Schloss Value

avoid · 18

Want this on a name you own?Send a ticker; we convene the full council on it.

Request Analysis →

Interparfums Inc

INTERPARFUMS INC (IPAR) — Council Assessment

🔴 AVOID · Score 34/100 · high confidence

360 narrative — news & sentiment digest

Interparfums (IPAR) — Investment Briefing

Management Commentary (Q3 2025 Earnings Call)

Recent Developments

Bull Narrative

Bear Narrative

Retail Sentiment

Caveats

Bull case

Bear case

Dissent — where the council disagrees

Key risks

Catalysts

DCF valuation (finance-expert model)

Short-sell evaluation

Council scorecard

Member reasoning

AI & Disruption Referee (Christensen-style) — 🟢 pass · 78/100 · medium confidence

Terry Smith (Fundsmith) — 🟡 watch · 58/100 · medium confidence

Warren Buffett — 🟡 watch · 55/100 · medium confidence

Chuck Akre — 🟡 watch · 52/100 · medium confidence

Philip Fisher — 🟡 watch · 52/100 · medium confidence

Charlie Munger — 🟡 watch · 52/100 · medium confidence

Forensic Short-Seller (Chanos/Einhorn-style) — 🟡 watch · 52/100 · medium confidence

Michael Mauboussin — 🟡 watch · 52/100 · medium confidence

Ray Dalio — 🟡 watch · 48/100 · medium confidence

Joel Greenblatt — 🔴 avoid · 32/100 · high confidence

Stanley Druckenmiller — 🔴 avoid · 28/100 · high confidence

Bruce Greenwald — 🔴 avoid · 28/100 · medium confidence

Peter Lynch — 🔴 avoid · 28/100 · high confidence

Valuation Referee (Damodaran-style) — 🔴 avoid · 22/100 · high confidence

Benjamin Graham — 🔴 avoid · 22/100 · high confidence

Howard Marks — 🔴 avoid · 22/100 · high confidence

Seth Klarman — 🔴 avoid · 18/100 · high confidence

Walter Schloss — 🔴 avoid · 18/100 · high confidence

Fact base appendix

AI & Disruption Referee (Christensen-style) Referee

Terry Smith (Fundsmith) Quality

Warren Buffett Quality

Chuck Akre Quality

Philip Fisher Growth

Charlie Munger Quality

Forensic Short-Seller (Chanos/Einhorn-style) Referee

Michael Mauboussin Quality

Ray Dalio Risk

Joel Greenblatt Value

Stanley Druckenmiller Risk

Bruce Greenwald Value

Peter Lynch Growth

Valuation Referee (Damodaran-style) Referee

Benjamin Graham Value

Howard Marks Risk

Seth Klarman Value

Walter Schloss Value